Vanguard Group »

Inhibrx shares owned by Vanguard Group

Quarter-by-quarter ownership of Inhibrx (INBX) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Inhibrx

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $71M 1.9M 38.00
2023-09-30 $33M 1.8M 18.35
2023-06-30 $46M 1.8M 25.96
2023-03-31 $34M 1.8M 18.87
2022-12-31 $43M 1.8M 24.64
2022-06-30 $15M 1.4M 11.35
2022-03-31 $27M 1.2M 22.28
2021-09-30 $23M 680k 33.31
2021-06-30 $14M 495k 27.52
2021-03-31 $7.8M 387k 20.04
2020-12-31 $13M 381k 33.00
2020-09-30 $540k 30k 17.99